Accessibility Menu
Ebos Group logo

Ebos Group(ASX) EBO

Market CapA$3.92BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2013)+259%
5 Year-28%
1 Year-47%
1 Month+2%
A$18.96
-3.17%
-0.62Today
Ebos Group last closing stock price
MetricPriceDate
Last closeAUD 18.962026-08-21
Ebos Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+7.24%AUD 17.682026-08-14
1 month+2.43%AUD 18.512026-07-22
3 month+14.49%AUD 16.562026-05-22
Year to date-17.65%AUD 23.022025-12-31
1 year-46.64%AUD 35.532025-08-21
3 year-32.32%AUD 28.012023-08-22
5 year-27.78%AUD 26.252021-08-20
Since inception+258.95%AUD 5.282013-12-06

Ebos Group Financials at a Glance

Market Cap

A$3.92BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$25.49B

Net Income (TTM)

A$435.83M

EPS (TTM)

A$1.09

P/E Ratio

17.27

Dividend

A$1.07

Beta (Volatility)

-0.03 (Low)

Price

A$18.96

Volume

118,844

Open

A$19.79

Previous Close

A$18.96

Daily Range

A$18.92 - A$19.79

52-Week Range

A$15.68 - A$36.36

Estimated Earnings Date

Feb 23, 2027

EBO News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ebos Group

Ebos Group Limited is a leading provider of healthcare, medical, pharmaceutical, and animal care products across Australia, Southeast Asia, and New Zealand. The company operates through two main segments: Healthcare and Animal Care, offering a diverse range of products and services tailored to meet the needs of its customers.

Products and Services
  • Healthcare logistics and medication management solutions
  • Pharmacy management software and consultancy services
  • Animal care products including nutrition and grooming supplies
Growth Outlook
  • Recent quarterly revenue reached NZD 7.61 billion, indicating strong demand
  • Net income for the latest quarter was NZD 140 million, showcasing profitability
  • Operating income margin improved to 2.8%, reflecting operational efficiency
Financial Highlights
  • Trailing twelve-month revenue of NZD 28.5 billion, demonstrating consistent growth
  • Dividend yield stands at 5.5%, appealing for income-focused investors
  • Current ratio of 1.24 indicates solid short-term financial health
Ebos Group Limited has established itself as a key player in the healthcare distribution sector, with a robust portfolio of products and services. The company's recent financial performance highlights its ability to generate significant revenue and maintain profitability, making it an attractive option for potential investors. The strong dividend yield further enhances its appeal, particularly for those seeking income-generating investments. With a focus on operational efficiency and a commitment to meeting customer needs, Ebos Group is well-positioned for continued growth in the evolving healthcare landscape.
AI Generated • Jul 24, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

6,200

CEO

Adam Luke Hall, MBA

Website

www.ebos.co.nz

Headquarters

Docklands, VIC 3008, AU

EBO Financials

Key Financial Metrics (TTM)

Gross Margin

7.09%

Operating Margin

2.80%

Net Income Margin

1.67%

Return on Equity

7.99%

Return on Capital

10.41%

Return on Assets

2.81%

Earnings Yield

5.79%

Dividend Yield

5.62%

Payout Ratio

58.73%

Stock Overview

Market Cap

A$3.92BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

206.97M

Volume

118.84K

Avg. Volume

114.56K

Financials (TTM)

Gross Profit

A$2.05B

Operating Income

A$863.23M

EBITDA

A$959.02M

Operating Cash Flow

A$764.79M

Capital Expenditure

-A$124.53M

Free Cash Flow

A$440.58M

Cash & ST Invst.

A$238.93M

Total Debt

A$704.97M

Ebos Group Performance Analysis

Ebos Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30AUD 12,237,401,00014.0%
20242024-06-30AUD 13,189,054,0007.8%
20252025-06-30AUD 12,266,898,000-7.0%
20262026-06-30AUD 13,486,684,0009.9%
Ebos Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-31-9.1%
Q42025-06-306.1%
Q22025-12-313.2%
Q42026-06-300.6%
Ebos Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30AUD 1.3316.1%
20242024-06-30AUD 1.416.3%
20252025-06-30AUD 1.09-22.9%
20262026-06-30AUD 1.090.1%
Ebos Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-31-56.3%
Q42025-06-3089.3%
Q22025-12-3111.3%
Q42026-06-30-18.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

A$6.60B

+0.2%

Gross Profit

A$469.41M

-42.6%

Gross Margin

7.11%

N/A

Market Cap

A$3.92BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$632.93K

N/A

Employees

6,200

N/A

Net Income

A$98.58M

-27.0%

EBITDA

A$188.16M

-31.4%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

A$238.93M

+10.5%

Total Debt

A$704.97M

-57.0%

Accounts Receivable

A$1.60B

+16.9%

Inventory

A$1.39B

+15.1%

Long Term Debt

A$1.74B

+113.3%

Short Term Debt

A$151.16M

-81.6%

Return on Assets

2.81%

N/A

Return on Invested Capital

7.48%

N/A

Free Cash Flow

A$228.53M

+8.5%

Operating Cash Flow

A$299.74M

+23.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MSB.AXMesoblast Limited
A$2.36-5.98%
ANN.AXAnsell Limited
A$34.90-1.05%
NEU.AXNeuren Pharmaceuticals Limited
A$22.46-2.94%
TLX.AXTelix Pharmaceuticals Limited
A$15.62-10.13%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.77+0.10%
IBITiShares Bitcoin Trust
$43.68+0.06%
BITOProShares Trust - ProShares Bitcoin ETF
$10.41+0.06%
MARAMara Holdings
$11.26+0.01%

Questions About EBO

What is the current price of Ebos Group?

Ebos Group is trading at A$18.96 per share.

What is the 52-week range for Ebos Group?

Over the past 52 weeks, Ebos Group has traded between A$15.68 and A$36.36.

How much debt does Ebos Group have?

As of the most recent reporting period, Ebos Group reported total debt of A$1.90B.

How much cash does Ebos Group have on hand?

Ebos Group reported A$239.09M in cash and cash equivalents in its most recent financial results.

What is Ebos Group’s dividend yield?

Ebos Group currently has a dividend yield of 5.62%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services